Nothing Special   »   [go: up one dir, main page]

WO2008079400A3 - Surgical applications for bmp binding protein - Google Patents

Surgical applications for bmp binding protein Download PDF

Info

Publication number
WO2008079400A3
WO2008079400A3 PCT/US2007/026315 US2007026315W WO2008079400A3 WO 2008079400 A3 WO2008079400 A3 WO 2008079400A3 US 2007026315 W US2007026315 W US 2007026315W WO 2008079400 A3 WO2008079400 A3 WO 2008079400A3
Authority
WO
WIPO (PCT)
Prior art keywords
binding protein
surgical applications
bmp binding
surgical
bone
Prior art date
Application number
PCT/US2007/026315
Other languages
French (fr)
Other versions
WO2008079400A2 (en
Inventor
Samuel S Murray
Elsa J Murray
Keyvan Behnam
Jeffrey C Wang
Original Assignee
Univ California
Us Dept Veterans Affairs
Samuel S Murray
Elsa J Murray
Keyvan Behnam
Jeffrey C Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/985,745 external-priority patent/US8193312B2/en
Application filed by Univ California, Us Dept Veterans Affairs, Samuel S Murray, Elsa J Murray, Keyvan Behnam, Jeffrey C Wang filed Critical Univ California
Priority to JP2009542969A priority Critical patent/JP5466017B2/en
Priority to US12/448,497 priority patent/US8415302B2/en
Priority to AU2007338627A priority patent/AU2007338627B2/en
Priority to EP07868028A priority patent/EP2115465A4/en
Priority to CA002673600A priority patent/CA2673600A1/en
Publication of WO2008079400A2 publication Critical patent/WO2008079400A2/en
Publication of WO2008079400A3 publication Critical patent/WO2008079400A3/en
Priority to US13/857,711 priority patent/US9050300B2/en
Priority to US14/731,852 priority patent/US9610320B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1841Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1875Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The present invention relates to the clinical application of BBP, alone or in combination with other growth factors, for use in bone healing applications, such as spinal surgery. Additional applications include use in orthopedic implantable prostheses and implantation into other surgical sites (e.g., surgical reconstruction, regional osteopenia, etc.) where bone is desired.
PCT/US2007/026315 2004-01-28 2007-12-26 Surgical applications for bmp binding protein WO2008079400A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2009542969A JP5466017B2 (en) 2006-12-22 2007-12-26 Surgical application for BMP binding proteins
US12/448,497 US8415302B2 (en) 2004-01-28 2007-12-26 Surgical applications for BMP binding protein
AU2007338627A AU2007338627B2 (en) 2006-12-22 2007-12-26 Surgical applications for BMP binding protein
EP07868028A EP2115465A4 (en) 2006-12-22 2007-12-26 Surgical applications for bmp binding protein
CA002673600A CA2673600A1 (en) 2006-12-22 2007-12-26 Surgical applications for bmp binding protein
US13/857,711 US9050300B2 (en) 2004-01-28 2013-04-05 Surgical applications for BMP binding protein
US14/731,852 US9610320B2 (en) 2004-01-28 2015-06-05 Surgical applications for BMP binding protein

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US87682106P 2006-12-22 2006-12-22
US60/876,821 2006-12-22
US11/985,745 2007-11-16
US11/985,745 US8193312B2 (en) 2004-01-28 2007-11-16 Bone morphogenic protein binding peptide

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/985,745 Continuation-In-Part US8193312B2 (en) 2004-01-28 2007-11-16 Bone morphogenic protein binding peptide

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/448,497 A-371-Of-International US8415302B2 (en) 2004-01-28 2007-12-26 Surgical applications for BMP binding protein
US13/857,711 Continuation US9050300B2 (en) 2004-01-28 2013-04-05 Surgical applications for BMP binding protein

Publications (2)

Publication Number Publication Date
WO2008079400A2 WO2008079400A2 (en) 2008-07-03
WO2008079400A3 true WO2008079400A3 (en) 2008-08-21

Family

ID=39563120

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/026315 WO2008079400A2 (en) 2004-01-28 2007-12-26 Surgical applications for bmp binding protein

Country Status (5)

Country Link
EP (1) EP2115465A4 (en)
JP (1) JP5466017B2 (en)
AU (1) AU2007338627B2 (en)
CA (1) CA2673600A1 (en)
WO (1) WO2008079400A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8415302B2 (en) 2004-01-28 2013-04-09 The Regents Of The University Of California Surgical applications for BMP binding protein
US8193312B2 (en) * 2004-01-28 2012-06-05 The Regents Of The University Of California Bone morphogenic protein binding peptide
US8188219B2 (en) 2004-01-28 2012-05-29 The Regents Of The University Of California Bone morphogenic protein binding peptide
CA2589930C (en) 2004-11-29 2016-10-11 The Regents Of The University Of California Activating extraction of demineralized bone matrix
MX2012000214A (en) 2009-06-23 2012-01-25 Univ California Enhancement of bmp retention.
JP2018525446A (en) * 2015-08-25 2018-09-06 ヒスタイド アクツィエンゲゼルシャフト Tissue formation inducing compound and use thereof
AU2016311300B2 (en) * 2015-08-25 2021-07-29 Histide Ag Compounds for inducing tissue formation and uses thereof
EP3833377B1 (en) * 2018-08-10 2023-11-22 Alexion Pharmaceuticals, Inc. Bone healing at implants using alkaline phosphatase
CN117042791A (en) 2021-02-12 2023-11-10 阿雷克森制药公司 Alkaline phosphatase polypeptides and methods of use thereof
EP4367131A1 (en) * 2021-07-05 2024-05-15 Universiteit Maastricht Means and methods for the treatment of calcium crystal deposition diseases

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072403A2 (en) * 2004-01-28 2005-08-11 The Regents Of The University Of California Bone morphogenic protein binding peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2020729A1 (en) * 1989-07-19 1991-01-20 Michael C. Kiefer Bone morphogenetic protein
CA2589930C (en) * 2004-11-29 2016-10-11 The Regents Of The University Of California Activating extraction of demineralized bone matrix

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072403A2 (en) * 2004-01-28 2005-08-11 The Regents Of The University Of California Bone morphogenic protein binding peptide

Also Published As

Publication number Publication date
EP2115465A2 (en) 2009-11-11
EP2115465A4 (en) 2011-08-10
CA2673600A1 (en) 2008-07-03
AU2007338627B2 (en) 2013-08-15
JP5466017B2 (en) 2014-04-09
WO2008079400A2 (en) 2008-07-03
AU2007338627A2 (en) 2010-01-28
AU2007338627A1 (en) 2008-07-03
JP2010513535A (en) 2010-04-30

Similar Documents

Publication Publication Date Title
WO2008079400A3 (en) Surgical applications for bmp binding protein
Magnan et al. Acrylic bone cement: current concept review
WO2006047310A3 (en) Hollow and porous orthopaedic or dental implant that delivers a biological agent
WO2007120539A3 (en) Orthopedic device
ATE524121T1 (en) DEVICES FOR PLACING AN ORTHOPEDIC INTERVERTEBRAL IMPLANT
WO2008021319A3 (en) Spinal motion preservation devices and methods of use
WO2007067726A3 (en) Apparatus and methods for treating bone
Woon et al. Induced membranes—a staged technique of bone-grafting for segmental bone loss: a report of two cases and a literature review
EP2498723A4 (en) Spinal implant configured for lateral insertion
WO2005034852A3 (en) Protein biomaterials and biocoacervates and methods of making and using thereof
WO2008070806A3 (en) Hard tissue anchors and delivery devices
WO2008079672A3 (en) Flowable carrier compositions for orthopedic implants and methods of use
DE69928246D1 (en) DEVICE FOR SPONDYLODESIS WITH IMPLANTED PARTS
WO2006049797A3 (en) Prefracture spinal implant for osteoporotic unfractured bone
IL188321A0 (en) Surgical access instruments for use with spinal or orthopedic surgery
WO2009120513A3 (en) Malleable multi-component implants and materials therefor
BR112012011288A2 (en) facet distraction device, joint facet implant and associated methods
ATE506035T1 (en) SPHERE-SHAPED SPINE IMPLANT
WO2006009452A3 (en) Bioresorbable bone implant
WO2007100459A3 (en) Surgical slings
CA2906846C (en) Medical implant for fixation and integration with hard tissue
WO2010003696A3 (en) Bone implant application
Simpson et al. Current treatment of infected non-union after intramedullary nailing
Metsemakers et al. Influence of implant properties and local delivery systems on the outcome in operative fracture care
WO2008130956A3 (en) Knee and shoulder joint prosthesis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07868028

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2009542969

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2673600

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007338627

Country of ref document: AU

Ref document number: 2007868028

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2007338627

Country of ref document: AU

Date of ref document: 20071226

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12448497

Country of ref document: US